GoodRx Holdings (GDRX) Income from Continuing Operations (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Income from Continuing Operations data on file, last reported at 1169000.0 in Q1 2026.

• For the quarter ending Q1 2026, Income from Continuing Operations fell 89.42% year-over-year to 1169000.0; the trailing twelve-month figure through Mar 2026 stood at 20556000.0 (down 27.75% YoY), and the FY2025 full-year result was 30439000.0, up 85.72% from the prior year.
• Income from Continuing Operations fell to 1169000.0 in Q1 2026, from 5425000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 58786000.0 in Q2 2023 to a low of 41734000.0 in Q3 2022.
• A 5-year average of 370705.88 and a median of 1169000.0 in 2026 frame the typical range for Income from Continuing Operations.
• Peak annual rise in Income from Continuing Operations reached 4254.49% in 2023, while the deepest fall reached 1211.82% in 2023.
• Tracing GDRX's Income from Continuing Operations over 5 years: stood at 1972000.0 in 2022, then tumbled by 1211.82% to 25869000.0 in 2023, then surged by 126.05% to 6740000.0 in 2024, then dropped by 19.51% to 5425000.0 in 2025, then plunged by 78.45% to 1169000.0 in 2026.
• Business Quant data shows GDRX's Income from Continuing Operations at 1169000.0 in Q1 2026, 5425000.0 in Q4 2025, and 1119000.0 in Q3 2025.